# Pitfalls in Veterinary Endocrine Testing

## Quick Answer

- Endocrine test results can mislead clinical decisions when stress, concurrent drugs, or assay artifacts alter measured hormone concentrations.
- Confirm abnormal results with repeat testing, alternative assay methods, or dynamic function tests before committing to a diagnosis.
- No single endocrine test is error-free, and reference intervals vary by species, age, assay platform, and laboratory.

## Understanding Endocrine Testing in Veterinary Medicine

Endocrine testing in veterinary medicine aims to quantify hormone concentrations to diagnose conditions such as hypothyroidism, hyperadrenocorticism, diabetes mellitus, and reproductive disorders. The clinical value of these tests depends on the assumption that the measured hormone level accurately reflects the physiologic state of the animal. That assumption fails under many common conditions. Stress, concurrent illness, and medications can shift hormone concentrations outside the reference interval in animals with normal endocrine function. Conversely, assay interference can produce falsely normal results in animals with genuine endocrine disease.

The consequences of misinterpretation are substantial. A false diagnosis of hypothyroidism leads to unnecessary lifelong levothyroxine supplementation. A missed diagnosis of hyperadrenocorticism delays treatment for a progressive disease. The clinician who understands the sources of error can interpret results within the context of the individual patient and the specific assay used. This article systematically reviews the common causes of erroneous endocrine results across thyroid, adrenal, pancreatic, and reproductive testing, with practical mitigation strategies for each.

## At a Glance

| Test Category | Common Pitfall | Typical Consequence | Mitigation Strategy |
| --- | --- | --- | --- |
| Thyroid panel | Euthyroid sick syndrome lowers total T4 in nonthyroidal illness | False hypothyroidism diagnosis | Use free T4 by equilibrium dialysis and TSH together with clinical signs |
| Adrenal function | Stress-induced cortisol elevation during ACTH stimulation | False hyperadrenocorticism diagnosis | Perform testing in a calm setting and interpret with urine cortisol-to-creatinine ratio |
| Pancreatic function | Lipemia or hemolysis interferes with insulin and fructosamine assays | Unreliable glucose or insulin values | Fast the patient, use serum separator tubes, and rerun after clearing lipemia |
| Reproductive hormones | Progesterone assay cross-reactivity with other steroids | Incorrect ovulation timing | Use the same assay platform for serial samples and confirm with ultrasound |

## 2. Thyroid Testing Pitfalls

### 2.1 Total T4 and the Euthyroid Sick Syndrome

Total thyroxine (T4) is the most commonly measured thyroid hormone in dogs and cats. It is a useful screening test because a normal total T4 concentration effectively rules out hypothyroidism in most dogs. The problem arises when total T4 is low in a patient that does not have thyroid disease. Any systemic illness can suppress the hypothalamic-pituitary-thyroid axis, reducing circulating T4 concentrations. This phenomenon is called euthyroid sick syndrome or nonthyroidal illness. It is common in dogs with renal failure, hepatic disease, gastrointestinal disease, and many other conditions.

The Merck Veterinary Manual describes the diagnostic approach to endocrine disorders and emphasizes that clinical signs must be interpreted alongside laboratory results. A low total T4 in a dog with a chronic skin condition but no other signs of hypothyroidism should not be accepted as a diagnosis. The clinician should instead measure free T4 by equilibrium dialysis, which is less affected by nonthyroidal illness, and consider a thyroid-stimulating hormone (TSH) concentration. A dog with true hypothyroidism typically has a low free T4 and a high TSH. A dog with euthyroid sick syndrome may have a low total T4 but a normal free T4 and a normal TSH.

### 2.2 Drug Effects on Thyroid Hormone Concentrations

Several medications alter thyroid hormone concentrations in predictable ways. Glucocorticoids suppress TSH secretion and reduce total T4 concentrations. Phenobarbital increases hepatic metabolism of thyroid hormones and can lower total T4. Sulfonamide antibiotics can inhibit thyroid hormone synthesis. A dog receiving any of these drugs may have a low total T4 without true hypothyroidism.

The clinician should always review the medication history before interpreting a thyroid panel. If a drug is known to affect thyroid hormone concentrations, the test should be repeated after the drug is withdrawn, if that is safe and feasible. If the drug cannot be withdrawn, the clinician should rely on free T4 by equilibrium dialysis and TSH, and should interpret the results with caution.

### 2.3 Feline Hyperthyroidism and Assay Artifacts

Feline hyperthyroidism is diagnosed by a high total T4 concentration in a cat with compatible clinical signs. The test is highly specific when the total T4 is clearly above the reference interval. However, early hyperthyroidism can present with a total T4 in the upper half of the reference interval, and some cats with nonthyroidal illness can have a total T4 that is suppressed into the normal range. In these cases, the clinician may need to repeat the test or use a free T4 by equilibrium dialysis.

The reverse problem also occurs. Some cats with chronic kidney disease or other nonthyroidal illness can have a total T4 that is mildly elevated, leading to a false diagnosis of hyperthyroidism. The clinician should always correlate the laboratory result with the clinical signs and consider a thyroid scan or a trial of antithyroid medication only when the diagnosis is secure.

### 2.4 Thyroid Testing in Other Species

Thyroid testing is not limited to dogs and cats. Horses can develop thyroid adenomas and hypothyroidism, and the same principles of interpretation apply. The total T4 in horses is affected by season, age, and concurrent illness. A single low total T4 in a horse with a poor hair coat should not be used to justify thyroid hormone supplementation. The clinician should measure free T4 and TSH, and should consider the possibility of a pituitary pars intermedia dysfunction (PPID) as a cause of the clinical signs.

## 3. Adrenal Function Testing Pitfalls

### 3.1 The Dexamethasone Suppression Test

The low-dose dexamethasone suppression test (LDDST) is a standard test for hyperadrenocorticism in dogs. The test measures cortisol concentrations before and after the administration of a low dose of dexamethasone. In a normal dog, the dexamethasone suppresses cortisol production. In a dog with hyperadrenocorticism, the cortisol remains elevated.

The LDDST is sensitive for the diagnosis of hyperadrenocorticism, but it is not specific. Stress, concurrent illness, and some drugs can cause a false-positive result. A dog that is anxious or painful during the test may have a cortisol concentration that does not suppress, even though it does not have hyperadrenocorticism. The clinician should minimize stress during the test, use a quiet room, and consider the possibility of a false-positive result if the clinical signs are not typical.

### 3.2 The ACTH Stimulation Test

The ACTH stimulation test measures the adrenal response to an injection of synthetic ACTH. It is used to diagnose hyperadrenocorticism and to monitor the response to treatment. The test is less sensitive than the LDDST for the diagnosis of hyperadrenocorticism, but it is more specific. A dog with a normal ACTH stimulation test is unlikely to have hyperadrenocorticism.

The ACTH stimulation test is also affected by stress, but the effect is less pronounced than with the LDDST. The test is more useful for monitoring the response to treatment with trilostane or mitotane, because the goal is to maintain the cortisol concentration within a target range.

### 3.3 The Urine Cortisol-to-Creatinine Ratio

The urine cortisol-to-creatinine ratio (UCCR) is a screening test for hyperadrenocorticism. It is measured on a free-catch urine sample collected at home, which avoids the stress of the hospital environment. A normal UCCR makes hyperadrenocorticism unlikely. An elevated UCCR is not diagnostic, because stress and other illnesses can elevate the ratio.

The UCCR is most useful as a screening test. If the ratio is normal, the clinician can be confident that the dog does not have hyperadrenocorticism. If the ratio is elevated, the clinician should proceed to a LDDST or an ACTH stimulation test to confirm the diagnosis.

### 3.4 Adrenal Testing in Cats

Hyperadrenocorticism is uncommon in cats, but it does occur. The diagnosis is more difficult than in dogs, because the LDDST and the ACTH stimulation test are less sensitive in cats. The UCCR is also less reliable in cats. The clinician may need to use a combination of tests and imaging to make the diagnosis.

### 3.5 The Effect of Drugs on Adrenal Testing

Several drugs can affect the results of adrenal function tests. Glucocorticoids, including topical and ophthalmic preparations, can suppress the adrenal axis and cause a false-negative ACTH stimulation test. Progestins, such as megestrol acetate, can also suppress the adrenal axis. The clinician should ask about all medications, including topical and ophthalmic drugs, before interpreting an adrenal test.

## 4. Pancreatic Endocrine Testing Pitfalls

### 4.1 Glucose and the Diagnosis of Diabetes Mellitus

The diagnosis of diabetes mellitus is based on a persistent hyperglycemia and glucosuria. A single blood glucose concentration above the reference interval is not sufficient for the diagnosis, because stress can cause a transient hyperglycemia in cats. The clinician should confirm the hyperglycemia with a second sample and should document glucosuria.

The stress hyperglycemia is a common problem in cats. A cat that is anxious or painful during the blood collection can have a glucose concentration that is above the reference interval, but the cat does not have diabetes. The clinician should measure the glucose again after the cat has been in the hospital for a few hours, or use a fructosamine concentration to assess the average glucose over the previous two to three weeks.

### 4.2 Fructosamine and Glycated Hemoglobin

Fructosamine is a glycated protein that reflects the average glucose concentration over the previous two to three weeks. It is useful for confirming a diagnosis of diabetes mellitus and for monitoring the response to treatment. Fructosamine is not affected by the stress of the blood sample, but it is affected by the protein concentration. A low protein concentration can cause a falsely low fructosamine, and a high protein concentration can cause a falsely high fructosamine.

Glycated hemoglobin (HbA1c) is a similar test that reflects the average glucose concentration over the previous two to three months. It is less commonly used in veterinary medicine than fructosamine, but it is available.

### 4.3 Insulin Assays and the Diagnosis of Insulinoma

Insulinoma is a pancreatic tumor that secretes insulin and causes hypoglycemia. The diagnosis is based on a low glucose concentration and a high insulin concentration. The insulin concentration must be interpreted with the glucose concentration. A high insulin concentration in a normoglycemic patient is not diagnostic of an insulinoma. The clinician should measure the glucose and insulin in the same sample and calculate the insulin-to-glucose ratio.

The insulin assay is affected by hemolysis and lipemia. A hemolyzed sample can cause a falsely low insulin concentration, and a lipemic sample can cause a falsely elevated insulin concentration. The clinician should ensure that the sample is collected in a serum separator tube and that the serum is clear before the assay.

### 4.4 Pancreatic Lipase and the Diagnosis of Pancreatitis

Pancreatic lipase is a marker of pancreatitis. The test is useful for the diagnosis of pancreatitis, but it is not specific. The lipase can be elevated in other conditions, such as renal failure, and it can be normal in some cases of pancreatitis. The clinician should interpret the lipase concentration with the clinical signs and the results of other tests.

## 5. Reproductive Hormone Testing Pitfalls

### 5.1 Progesterone and Ovulation Timing

Progesterone is used to time ovulation in dogs and to confirm pregnancy. The progesterone concentration rises after ovulation, and the clinician can use the concentration to predict the optimal time for breeding. The problem is that the progesterone assay is not standardized, and the results can vary between laboratories and between assay platforms.

The clinician should use the same laboratory and the same assay for serial samples. The progesterone concentration should be interpreted with the clinical signs of estrus and the vaginal cytology. The clinician should not rely on a single progesterone concentration to time the breeding.

### 5.2 Testosterone and the Diagnosis of Cryptorchidism

Testosterone is used to diagnose cryptorchidism in dogs. The testosterone concentration is measured before and after the administration of human chorionic gonadotropin (hCG) or gonadotropin-releasing hormone (GnRH). A dog with a retained testicle will have an elevated testosterone concentration after the stimulation.

The testosterone assay is affected by the same factors as other hormone assays. The clinician should ensure the sample is clean and the assay is reliable. The testosterone concentration can be falsely low if the sample is hemolyzed or if the dog is receiving a drug that suppresses testosterone.

### 5.3 The Use of the Same Assay for Serial Samples

The most important principle in reproductive hormone testing is to use the same assay for serial samples. The progesterone concentration can vary between assays, and the clinician should not compare a progesterone concentration from one laboratory with a concentration from another laboratory. The clinician should use the same laboratory and the same assay for all samples in a breeding cycle.

## 6. Assay Artifacts and Laboratory Errors

### 6.1 Hemolysis, Lipemia, and Icterus

Hemolysis, lipemia, and icterus are the most common causes of assay artifacts. Hemolysis can interfere with the assay of many hormones, including insulin, cortisol, and thyroid hormones. Lipemia can interfere with the assay of the same hormones. Icterus can interfere with the assay of some hormones.

The clinician should ensure that the blood sample is collected in a clean tube and that the serum is separated from the clot as soon as possible. The clinician should also check the sample for hemolysis, lipemia, and icterus before the assay. If the sample is affected, the clinician should repeat the sample.

### 6.2 The Effect of the Assay Platform

The assay platform can affect the results of the hormone assay. The same hormone can be measured with different assays, and the results can vary between the assays. The clinician should use the same assay for serial samples and should interpret the results with the reference interval for the specific assay.

### 6.3 The Effect of the Laboratory

The laboratory can also affect the results of the hormone assay. The same sample can be measured in different laboratories, and the results can vary between the laboratories. The clinician should use the same laboratory for serial samples and should interpret the results with the reference interval for the specific laboratory.

## 7. The Clinical Approach to Endocrine Testing

### 7.1 The Importance of the Clinical Signs

The clinical signs are the most important part of the endocrine testing. The clinician should not use the laboratory result to make a diagnosis without the clinical signs. The laboratory result should be used to confirm the diagnosis, not to make the diagnosis.

### 7.2 The Use of the Reference Interval

The reference interval is the range of values that is expected in a healthy population. The reference interval is specific to the assay and the laboratory. The clinician should use the reference interval for the specific assay and the specific laboratory.

### 7.3 The Use of the Dynamic Function Test

The dynamic function test is a test that measures the response of the endocrine system to a stimulus. The dynamic function test is more useful than the static test for the diagnosis of some endocrine disorders. The dynamic function test can be used to confirm the diagnosis of hyperadrenocorticism, hypothyroidism, and other disorders.

### 7.4 The Use of the Imaging

The imaging can be used to confirm the diagnosis of some endocrine disorders. The ultrasound can be used to confirm the diagnosis of hyperadrenocorticism, and the thyroid scan can be used to confirm the diagnosis of hyperthyroidism.

## 8. Common Failure Patterns in Endocrine Testing

### 8.1 The False Positive

The false positive is a test result that is abnormal in a patient who does not have the disease. The false positive is caused by the stress, the concurrent illness, or the assay artifact. The clinician should be aware of the false positive and should confirm the diagnosis with a repeat test or a dynamic function test.

### 8.2 The False Negative

The false negative is a test result that is normal in a patient who has the disease. The false negative is caused by the early stage of the disease, the concurrent illness, or the assay artifact. The clinician should be aware of the false negative and should repeat the test or use a dynamic function test.

### 8.3 The Misinterpretation of the Result

The misinterpretation of the result is the most common failure pattern. The clinician should interpret the result with the clinical signs and the reference interval. The clinician should not use the result to make a diagnosis without the clinical signs.

## 9. The Role of the Laboratory in Endocrine Testing

### 9.1 The Quality Control

The laboratory should have a quality control program to ensure the accuracy of the assay. The quality control program should include the use of the control samples and the monitoring of the assay performance.

### 9.2 The Quality Assurance

The laboratory should have a quality assurance program to ensure the accuracy of the results. The quality assurance program should include the use of the internal and external quality control.

### 9.3 The Communication with the Clinician

The laboratory should communicate with the clinician about the results. The laboratory should provide the reference interval and the information about the assay. The laboratory should also provide the information about the limitations of the assay.

## 10. The Welfare and Safety Context

The welfare of the animal is the most important consideration in the endocrine testing. The clinician should minimize the stress of the animal during the blood sample and the test. The clinician should also ensure that the animal is not harmed by the test.

The safety of the animal is also important. The clinician should ensure that the animal is not harmed by the test. The clinician should also ensure that the animal is not harmed by the treatment.

## 11. The Professional Escalation Criteria

The clinician should escalate the case to a specialist if the diagnosis is not clear. The clinician should also escalate the case to a specialist if the treatment is not effective. The clinician should also escalate the case to a specialist if the animal is not stable.

## 12. The Records and Measurements

The clinician should keep the records of the endocrine testing. The records should include the date of the test, the result of the test, and the interpretation of the result. The records should also include the clinical signs and the treatment.

## 13. The Common Failure Patterns

The common failure patterns in the endocrine testing are the false positive, the false negative, and the misinterpretation of the result. The clinician should be aware of the common failure patterns and should avoid them.

## 14. The Limitations of the Endocrine Testing

The endocrine testing is not perfect. The endocrine testing has the limitations. The clinician should be aware of the limitations and should interpret the results with the clinical context.

## 15. The Future of the Endocrine Testing

The future of the endocrine testing is the use of the new assays and the new technologies. The future of the endocrine testing is the use of the point-of-care testing and the use of the telemedicine.

## A Practical Decision Framework for Endocrine Test Interpretation

### The Need for a Structured Approach

The preceding sections have detailed the many ways endocrine test results can mislead. Stress, concurrent medications, and assay artifacts each create their own failure modes. A clinician facing a single abnormal result must decide quickly whether to accept the result, repeat the test, pursue a dynamic function test, or escalate to a specialist. Without a structured approach, the decision often defaults to repeating the same test under the same conditions, which reproduces the same error.

A practical decision framework addresses this problem directly. It forces the clinician to answer a fixed set of questions before any endocrine result is accepted as diagnostic. The framework is not a substitute for clinical judgment. It is a checklist that ensures the judgment is applied consistently and that no common source of error is overlooked. The framework is built around four gates: sample quality, drug exposure, stress context, and clinical concordance. Each gate must be passed before a result is used to make a treatment decision.

### Gate 1: Sample Quality Assessment

The first gate addresses the physical condition of the sample. Hemolysis, lipemia, and icterus are the most common assay artifacts, and they are also the most preventable. The clinician should inspect every endocrine sample before it is sent to the laboratory. A sample that is visibly hemolyzed should be redrawn instead of submitted, because the laboratory cannot reliably correct for the interference.

The assessment is simple and requires no special equipment. After centrifugation, the serum or plasma should be clear and free of red discoloration. A pink or red tint indicates hemolysis. A milky or turbid appearance indicates lipemia. A yellow tint indicates icterus. Each of these conditions can interfere with hormone assays in different ways. Hemolysis can falsely lower insulin and falsely elevate some steroid assays. Lipemia can falsely elevate insulin and interfere with thyroid hormone measurements. The clinician should record the appearance of the sample on the submission form and in the medical record.

The timing of sample handling is equally important. Serum should be separated from the clot within 30 to 60 minutes of collection. Prolonged contact with the clot allows cellular metabolism to continue, which can alter glucose and hormone concentrations. The sample should be stored and shipped according to the laboratory specifications. Some hormones are stable at room temperature for a short period, while others require refrigeration or freezing. The clinician should know the stability requirements for each hormone before the sample is collected.

### Gate 2: Drug Exposure Review

The second gate is a systematic review of every drug the animal has received in the weeks before the test. This includes prescription drugs, over-the-counter products, topical preparations, and ophthalmic medications. The clinician should not assume that a drug is irrelevant because it is applied to the skin or the eye. Glucocorticoids, including topical and ophthalmic forms, can suppress the adrenal axis and alter thyroid hormone concentrations. Progestins can suppress the adrenal axis and affect reproductive hormone assays.

The drug review should be documented in the medical record. The clinician should list each drug, the dose, the route, and the duration of treatment. The review should also include any drug that was discontinued in the past two to four weeks, because some drugs have a prolonged effect on hormone concentrations. Phenobarbital, for example, induces hepatic enzymes and can lower total T4 for weeks after the drug is discontinued.

The decision to withdraw a drug before testing is a clinical judgment. The clinician must weigh the risk of withdrawing the drug against the benefit of a more reliable test result. For a drug that is essential for the animal's health, the test should be interpreted with the drug effect in mind. For a drug that can be safely withdrawn, the test should be repeated after a washout period. The washout period should be based on the drug's half-life and the known duration of its effect on the endocrine system.

### Gate 3: Stress Context Assessment

The third gate is the stress context. Stress is the most common cause of false endocrine results in veterinary medicine. The stress of the hospital visit, the blood collection, and the restraint can elevate cortisol and glucose concentrations. The stress response is not limited to the adrenal axis. It can also affect thyroid hormone concentrations and reproductive hormone concentrations.

The clinician should assess the stress level of the animal before the test. A dog that is trembling, panting, or attempting to escape is stressed. A cat that is hissing, growling, or hiding is stressed. The stress assessment should be recorded in the medical record. The clinician should note the animal's behavior during the blood collection and the test procedure.

The stress context is particularly important for the low-dose dexamethasone suppression test. A stressed dog can have a cortisol concentration that does not suppress, even though the dog does not have hyperadrenocorticism. The test should be performed in a quiet room with minimal handling. The clinician should consider the use of a pheromone product or a quiet environment to reduce stress. The stress context should be interpreted with the clinical signs. A dog with a non-suppressing cortisol concentration but no clinical signs of hyperadrenocorticism should not be diagnosed with the disease.

### Gate 4: Clinical Concordance Check

The fourth gate is the clinical concordance. The laboratory result must be consistent with the clinical signs and the physical examination findings. A diagnosis of hypothyroidism should not be made in a dog with a low total T4 but no clinical signs of hypothyroidism. A diagnosis of hyperadrenocorticism should not be made in a dog with an elevated cortisol but no clinical signs of the disease.

The clinical concordance check is a simple question: does the result make sense for this animal? The clinician should list the clinical signs that support the diagnosis and the clinical signs that do not. The result should be interpreted in the context of the entire clinical picture. A result that is inconsistent with the clinical signs should be repeated or confirmed with a dynamic function test.

The clinical concordance check also includes the signalment of the animal. Age, breed, and sex can affect the reference interval and the likelihood of disease. A low total T4 in a young dog is more likely to be a false result than a low total T4 in an older dog with classic signs of hypothyroidism. A high cortisol in a dog with a history of polyuria, polydipsia, and a pot-bellied appearance is more likely to be a true result than a high cortisol in a dog with no clinical signs.

### The Decision Matrix

The four gates can be combined into a decision matrix. The matrix is a simple tool that guides the clinician through the interpretation process. The matrix has four columns: the gate, the question, the action if the gate is passed, and the action if the gate is failed.

| Gate | Question | Action if Passed | Action if Failed |
| --- | --- | --- | --- |
| Sample quality | Is the sample free of hemolysis, lipemia, and turbidity? | Proceed to the next gate | Redraw the sample and repeat the test |
| Drug exposure | Is the animal free of drugs that affect the assay? | Proceed to the next gate | Withdraw the drug if safe, or interpret with caution |
| Stress context | Is the animal calm and unstressed? | Proceed to the next gate | Repeat the test in a calm setting or use a stress-independent test |
| Clinical concordance | Is the result consistent with the clinical signs? | Use the result to guide treatment | Repeat the test or use a dynamic function test |

The matrix is applied in order. A sample that fails the first gate is redrawn before any further interpretation. A sample that passes the first gate but fails the second gate is interpreted with the drug effect in mind. A sample that passes the first two gates but fails the third gate is repeated in a calm setting. A sample that passes the first three gates but fails the fourth gate is investigated further.

### The Record System for Endocrine Testing

The decision framework is only useful if the clinician records the information needed to apply it. A structured record system ensures that the gates are applied consistently and that the information is available for future reference. The record should include the following elements for each endocrine test:

The date and time of the sample collection. The sample type, including serum, plasma, or urine. The appearance of the sample, including hemolysis, lipemia, or icterus. The drug list, including the dose, route, and duration of each drug. The stress assessment, including the behavior of the animal during the test. The clinical signs that are present and the clinical signs that are absent. The laboratory result and the reference interval for the specific assay. The interpretation of the result, including the gate that was passed or failed.

The record should be maintained in the medical record and should be reviewed at each subsequent visit. The record allows the clinician to track the results over time and to identify trends. A dog with a low total T4 that is repeated after the withdrawal of a drug should show an improvement in the total T4 concentration. A dog with a high cortisol that is repeated in a calm setting should show a lower cortisol concentration.

The record system also supports the communication with the laboratory. The clinician should provide the laboratory with the sample information, including the appearance of the sample and the drug list. The laboratory can use this information to interpret the result and to flag any potential interference. The clinician should also request the reference interval for the specific assay and the specific laboratory.

### The Troubleshooting Method for a Discordant Result

A discordant result is a result that is inconsistent with the clinical signs or with a previous result. The discordant result is the most common reason for a repeat test. The troubleshooting method is a structured approach to the discordant result. The method is based on the four gates and the record system.

The first step in the troubleshooting method is to review the record. The clinician should check the sample quality, the drug list, the stress assessment, and the clinical signs. The clinician should identify the gate that was failed. If the sample was hemolyzed, the sample should be redrawn. If the drug was present, the drug should be withdrawn if safe. If the animal was stressed, the test should be repeated in a calm setting. If the clinical signs are not consistent, the test should be repeated or a dynamic function test should be used.

The second step is to repeat the test under the corrected conditions. The repeat test should be performed with the same assay and the same laboratory. The clinician should not change the assay or the laboratory, because the results may not be comparable. The repeat test should be performed at the same time of day, if possible, to reduce the effect of diurnal variation.

The third step is to compare the results. The clinician should compare the first result with the second result. If the second result is normal and the first result was abnormal, the first result was likely a false positive. If the second result is abnormal and the first result was normal, the first result was likely a false negative. If both results are abnormal, the result is likely a true positive, and the clinician should proceed with the diagnosis.

The fourth step is to consider a dynamic function test. If the repeat test is still discordant, the clinician should use a dynamic function test to confirm the diagnosis. The dynamic function test is a test that measures the response of the endocrine system to a stimulus. The dynamic function test is more useful than the static test for the diagnosis of some endocrine disorders. The dynamic function test can be used to confirm the diagnosis of hyperadrenocorticism, hypothyroidism, and other disorders.

### The Comparison of the Framework with the Existing Approach

The existing approach to endocrine testing is often a single test followed by a diagnosis. The framework is a structured approach that requires the clinician to consider the sample quality, the drug exposure, the stress context, and the clinical concordance before the result is used. The framework is not a replacement for the clinical judgment. It is a tool that ensures the clinical judgment is applied consistently.

The framework is also a tool for the education of the client. The clinician can use the framework to explain to the client why a test is being repeated or why a dynamic function test is being used. The client is more likely to accept the recommendation when the clinician can explain the reasons for the test. The framework also supports the communication with the laboratory. The clinician can provide the laboratory with the information about the sample and the drug list, and the laboratory can use this information to interpret the results.

The framework is a tool for the quality improvement of the practice. The clinician can review the records of the endocrine testing to identify the common failure patterns. The clinician can use the records to identify the drugs that are commonly associated with the false results and the stress conditions that are commonly associated with the false results. The clinician can use this information to improve the testing protocols and to reduce the number of the false results.

### The Limitations of the Framework

The framework is not a substitute for the clinical judgment. The framework is a tool that guides the interpretation, but the clinician must still make the final decision. The framework is also not a substitute for the dynamic function test. The framework can identify the need for the dynamic function test, but the dynamic function test must be performed and interpreted by the clinician.

The framework is also limited by the quality of the information. The framework depends on the accuracy of the drug list and the stress assessment. The clinician must ask the client about all the drugs, including the topical and the ophthalmic drugs. The clinician must also assess the stress level of the animal accurately. The framework is also limited by the availability of the dynamic function test. The dynamic function test may not be available in all the practices, and the clinician may need to refer the animal to a specialist.

The framework is also limited by the reference interval. The reference interval is specific to the assay and the laboratory. The clinician must use the reference interval for the specific assay and the specific laboratory. The reference interval is also affected by the age, the sex, and the breed of the animal. The clinician must interpret the result with the reference interval for the specific animal.

### The Implementation of the Framework in Practice

The framework can be implemented in the practice with a simple change in the workflow. The clinician should add the four gates to the standard endocrine testing protocol. The clinician should record the sample quality, the drug list, the stress assessment, and the clinical concordance for each test. The clinician should use the four gates to interpret the result and to decide whether to repeat the test or to use a dynamic function test.

The implementation should be supported by the training of the staff. The staff should be trained to collect the sample correctly, to assess the stress level of the animal, and to record the drug list. The staff should also be trained to recognize the signs of the hemolysis, the lipemia, and the icterus. The staff should be trained to communicate with the client about the testing process.

The implementation should be supported by the quality improvement. The clinician should review the records of the endocrine testing on a regular basis. The clinician should identify the common failure patterns and the common causes of the false results. The clinician should use this information to improve the testing protocols and to reduce the number of the false tests.

The implementation should be supported by the communication with the laboratory. The clinician should provide the laboratory with the information about the sample and the drug list. The laboratory should provide the clinician with the reference interval and the information about the assay. The laboratory should also provide the clinician with the information about the limitations of the assay.

### The Professional Escalation Criteria

The framework includes the professional escalation criteria. The clinician should escalate the case to a specialist if the diagnosis is not clear after the framework is applied. The clinician should also escalate the case to a specialist if the treatment is not effective. The clinician should also escalate the case to a specialist if the animal is not stable.

The escalation criteria are based on the clinical judgment. The clinician should escalate the case if the clinical signs are severe or if the animal is not responding to the treatment. The clinician should also escalate the case if the clinician is not confident in the diagnosis. The escalation should be done in a timely manner to avoid the delay in the treatment.

The escalation criteria are also based on the availability of the specialist. The clinician should refer the animal to a specialist if the specialist is available. The clinician should also refer the animal to a specialist if the dynamic function test is not available in the practice. The referral should be done with the communication with the client and the specialist.

### The Welfare and Safety Context

The framework is designed to reduce the number of the false diagnoses and the unnecessary treatments. The false diagnosis of hypothyroidism leads to the unnecessary lifelong levothyroxine supplementation. The false diagnosis of hyperadrenocorticism leads to the unnecessary treatment with the trilostane or the mitotane. The false diagnosis of diabetes mellitus leads to the unnecessary insulin treatment. The framework reduces the risk of these unnecessary treatments.

The framework is also designed to reduce the stress of the animal. The framework includes the stress assessment and the recommendation to repeat the test in a calm setting. The framework also includes the recommendation to use the urine cortisol-to-creatinine ratio, which is collected at home and avoids the stress of the hospital environment. The framework supports the welfare of the animal.

The framework is also designed to support the safety of the animal. The framework includes the drug review. The framework recommends the withdrawal of the drug if it is safe. The framework also recommends the caution when the drug cannot be withdrawn. The framework supports the safety of the animal.

### The Records and Measurements

The framework requires the records of the endocrine testing. The records should include the date of the test, the result of the test, and the interpretation of the result. The records should also include the sample quality, the drug list, the stress assessment, and the clinical concordance. The records should be reviewed at each subsequent visit.

The records should be used to measure the performance of the framework. The clinician should measure the number of the false results and the number of the repeat tests. The clinician should also measure the number of the dynamic function tests and the number of the referrals to the specialist. The clinician should use these measurements to improve the framework.

The records should also be used to measure the outcome of the treatment. The clinician should measure the response to the treatment and the adverse effects of the treatment. The clinician should use these measurements to adjust the treatment and to improve the outcome.

### The Common Failure Patterns of the Framework

The framework is not perfect. The framework has the common failure patterns. The most common failure pattern is the failure to apply the framework. The clinician may skip the gates and interpret the result without the review. The clinician should be aware of this failure pattern and should apply the framework consistently.

The second common failure pattern is the failure to record the information. The clinician may not record the sample quality, the drug list, or the stress assessment. The clinician should be aware of this failure pattern and should record the information for each test.

The third common failure pattern is the failure to escalate the case. The clinician may not escalate the case to a specialist when the diagnosis is not clear. The clinician should be aware of this failure pattern and should escalate the case when the diagnosis is not clear.

### The Limitations of the Framework

The framework is a guide, not a rule. The framework is not a substitute for the clinical judgment. The framework is also not a substitute for the laboratory quality. The framework is limited by the quality of the laboratory and the quality of the assay. The framework is also limited by the availability of the dynamic function test and the specialist.

The framework is also limited by the reference interval. The reference interval is specific to the assay and the laboratory. The reference interval is also affected by the age, the sex, and the breed of the animal. The clinician must use the reference interval for the specific animal.

The framework is also limited by the clinical signs. The clinical signs are the most important part of the endocrine testing. The framework is designed to support the clinical signs, but the framework cannot replace the clinical signs. The clinician must use the clinical signs to interpret the result.

### The Future of the Framework

The framework can be adapted to the new assays and the new technologies. The framework can be used with the point-of-care testing and the telemedicine. The framework can also be used with the new biomarkers and the new dynamic function tests. The framework is a flexible tool that can be adapted to the changing clinical practice.

The framework can also be used for the education of the client. The framework can be used to explain the testing process to the client. The framework can also be used to explain the reasons for the repeat test and the dynamic function test. The framework supports the communication with the client.

The framework can also be used for the quality improvement of the practice. The framework can be used to identify the common failure patterns and the common causes of the false results. The framework can also be used to improve the testing protocols and to reduce the number of the false tests. The framework is a tool for the continuous improvement of the clinical practice.

## Frequently Asked Questions

### What is the most common cause of a false hypothyroidism diagnosis in dogs?

The most common cause is the euthyroid sick syndrome, where a concurrent nonthyroidal illness lowers the total T4 concentration. The clinician should confirm the diagnosis with a free T4 by equilibrium dialysis and a TSH concentration.

### How can I avoid a false hyperadrenocorticism diagnosis in a stressed dog?

Minimize stress during the test, use a comfortable environment, and interpret the result with the clinical signs. The LDDST is sensitive to stress, and a dog that is anxious or painful can have a cortisol concentration that does not suppress.

### What is the best way to confirm a diagnosis of diabetes mellitus in a cat?

The diagnosis should be confirmed with a repeat glucose concentration and a fructosamine concentration. The stress hyperglycemia is common in cats, and a single glucose concentration is not sufficient for the diagnosis.

### Why is the progesterone assay not reliable for ovulation timing?

The progesterone assay is not universal, and the results can vary between the laboratories and the assays. The clinician should use the same laboratory and the same assay for serial samples.

### What is the effect of hemolysis on the hormone assay?

Hemolysis can interfere with the assay of many hormones, including insulin, cortisol, and thyroid hormones. The clinician should ensure that the sample is clean and that the serum is separated from the clot as soon as possible.

### What is the role of the clinical signs in the endocrine testing?

The clinical signs are the most important clue in the endocrine testing. The clinician should not use the laboratory result to make a diagnosis without the clinical signs.

### What is the role of the dynamic function test in the endocrine testing?

The dynamic function test is a test that measures the response of the endocrine system to a stimulus. The dynamic function test is more useful than the static test for the diagnosis of some endocrine disorders.

### What is the role of the imaging in the endocrine testing?

The imaging can be used to confirm the diagnosis of some endocrine disorders. The ultrasound can be used to confirm the diagnosis of hyperadrenocorticism, and the thyroid scan can be used to confirm the diagnosis of hyperthyroidism.

## Related Veterinary Guides

- [Interpreting Endocrine Assay Results in Small Animals](/knowledge/veterinary-medicine/clinical-internal-medicine/interpreting-endocrine-assay-results-small-animals)
- [Anesthetic Machine Leak Testing and Pressure Checks: A Step-by-Step Protocol](/knowledge/veterinary-medicine/anesthesia-analgesia/anesthetic-machine-leak-testing-pressure-checks)
- [Coagulation Testing in Veterinary Medicine: A Practical Guide](/knowledge/veterinary-medicine/clinical-pathology/coagulation-testing-veterinary-practical-guide)
- [Meta-Analysis of Veterinary Diagnostic Test Accuracy](/knowledge/veterinary-medicine/veterinary-research-methods/meta-analysis-veterinary-diagnostic-test-accuracy)
- [Likelihood Ratios in Veterinary Diagnostic Testing](/knowledge/veterinary-medicine/veterinary-epidemiology/likelihood-ratios-veterinary-diagnostic-testing)

## References and Further Reading

- [Pet Care](https://www.avma.org/resources-tools/pet-owners). American Veterinary Medical Association.
- [AAHA Guidelines](https://www.aaha.org/resources). American Animal Hospital Association.
- [Global Guidelines](https://wsava.org/global-guidelines). World Small Animal Veterinary Association.
- [Merck Veterinary Manual](https://www.merckvetmanual.com/). Merck Veterinary Manual.
- [Cornell University College of Veterinary Medicine](https://www.vet.cornell.edu/). Cornell University.
- [Animal Health and Welfare](https://www.woah.org/en/what-we-do/animal-health-and-welfare). World Organisation for Animal Health.
- [Recent Advances in the Detection of Food Contaminants and Pollutants.](https://doi.org/10.3390/foods15061011). 2026.
- [Biological variation of baseline serum cortisol concentration in healthy dogs, part 1: variance components.](https://doi.org/10.3389/fvets.2026.1805880). 2026.
- [Fecal Microbiota Transplantation in Animals: Therapeutics, Conservation, and Farming.](https://doi.org/10.3390/microorganisms13112465). 2025.
- [Revisiting &lt,i&gt,Acalypha&lt,/i&gt, medicinal interest: ethnobotany, experimental studies, and the implications of taxonomic misuse pitfalls.](https://doi.org/10.3897/phytokeys.270.169087). 2026.
- [Mechanism of Action of Plant Extracts in Preventing Post-Weaning Diarrhea in Piglets: A Review.](https://doi.org/10.3390/vetsci13040312). 2026.

> This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.